Translation and interpreting services must be considered across the lifecycle of clinical trials [Commentary]

Roberts, Kirsty, Lewis, Rebecca, Iqbal, Gulnaz, Rick, Caroline and Shepherd, Victoria ORCID: https://orcid.org/0000-0002-7687-0817 2026. Translation and interpreting services must be considered across the lifecycle of clinical trials [Commentary]. Trials 27 , 534. 10.1186/s13063-026-09840-y

Preview

PDF - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Background Inclusive clinical research requires that all prospective participants are provided with accessible, comprehensible information to support informed decision-making regarding trial participation. However, people with limited English proficiency (LEP) remain disproportionately excluded from trials in English-speaking countries, largely due to insufficient translation and interpretation support. This exclusion compromises equity, participant safety, and the integrity and generalisability of trial findings.

Item Type:	Short Communication
Date Type:	Published Online
Status:	Published
Schools:	Schools > Medicine Research Institutes & Centres > Centre for Trials Research (CNTRR)
Publisher:	BioMed Central
Date of First Compliant Deposit:	22 June 2026
Date of Acceptance:	3 June 2026
Last Modified:	04 Sep 2026 08:54
URI:	https://orca.cardiff.ac.uk/id/eprint/187670

Actions (repository staff only)

Edit Item